News Release

Diabetes drug may hold potential as treatment for epilepsy

Peer-Reviewed Publication

American Society for Biochemistry and Molecular Biology

Metformine, a widely used diabetic drug, might also be an effective and safe therapy for epilepsy, researchers report. This new approach may be especially helpful for the subset of patients who have recurrent seizures despite therapy with the best available drugs.

The basis for metformine’s effect is similar to a ketogenic diet, which is an attempt to minimize dietary starch and sugar. Epilepsy patients have been using this severe dietary approach for centuries, which led Dr. Avtar Roopra and colleagues to wonder if drugs could tap into metabolic pathways and produce similar results.

The researchers identified a small molecule in neurons that senses how much energy is available on hand. Glucose normally turns on this sensor, but so does Metformine, a drug used to control blood sugar. By administering the proper dose, they could suppress over-active nerve cells by removing their ability to turn sugar into excess energy.

Roopra and colleagues now hope to apply their preliminary results to a mouse model of epilepsy.

###

Not for Public Release before: 4:20 p.m. PT, Tuesday, April 8

Author Pressroom availability: 10:00 a.m. PT, Tuesday, April 8

Meeting Contact: Sarah Goodwin, Phone: 770-722-0155 before April 5, 619-525-6227, April 5-April 9, Email: ebpress@gmail.com


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.